Position in SVRA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$440,670
+$126 QoQ
Shares Held
80,709
+10.5% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 184 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 21.37308106902576.ToString("F0")%
Shared 0.ToString("F0")%
None 78.62691893097424.ToString("F0")%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,578,634,665 across 404 Biotechnology names. SVRA ranks #194 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in SVRA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $440,670 | 80,709 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $440,544 | 73,059 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $227,890 | 63,835 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $156,197 | 68,508 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $6,048,737 | 2,183,660 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $4,369,035 | 1,423,139 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $294,636 | 69,490 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $229,991 | 57,070 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $831,617 | 166,992 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $405,811 | 86,343 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $232,790 | 61,585 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $189,763 | 59,394 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $115,297 | 59,127 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $38,335 | 24,733 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $33,345 | 21,514 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $34,869 | 22,941 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $44,446 | 33,929 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $198,591 | 160,155 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $75,759 | 54,899 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $361,528 | 212,664 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $329,406 | 158,369 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $165,287 | 143,729 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $19,610 | 17,992 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $38,982 | 15,656 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $23,587 | 11,126 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||